6CGX

Backbone cyclised conotoxin Vc1.1 mutant - D11A, E14A

  • Classification: TOXIN
  • Organism(s): Conus victoriae
  • Mutation(s): Yes 

  • Deposited: 2018-02-21 Released: 2018-05-23 
  • Deposition Author(s): Clark, R.J.
  • Funding Organization(s): National Health and Medical Research Council (NHMRC, Australia), Australian Research Council (ARC)

Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 100 
  • Conformers Submitted: 20 
  • Selection Criteria: structures with the lowest energy 

wwPDB Validation   3D Report Full Report


This is version 1.3 of the entry. See complete history


Literature

Structure-Activity Studies Reveal the Molecular Basis for GABAB-Receptor Mediated Inhibition of High Voltage-Activated Calcium Channels by alpha-Conotoxin Vc1.1.

Sadeghi, M.Carstens, B.B.Callaghan, B.P.Daniel, J.T.Tae, H.S.O'Donnell, T.Castro, J.Brierley, S.M.Adams, D.J.Craik, D.J.Clark, R.J.

(2018) ACS Chem Biol 13: 1577-1587

  • DOI: https://doi.org/10.1021/acschembio.8b00190
  • Primary Citation of Related Structures:  
    6CGX

  • PubMed Abstract: 

    α-Conotoxins are disulfide-bonded peptides from cone snail venoms and are characterized by their affinity for nicotinic acetylcholine receptors (nAChR). Several α-conotoxins with distinct selectivity for nAChR subtypes have been identified as potent analgesics in animal models of chronic pain. However, a number of α-conotoxins have been shown to inhibit N-type calcium channel currents in rodent dissociated dorsal root ganglion (DRG) neurons via activation of G protein-coupled GABA B receptors (GABA B R). Therefore, it is unclear whether activation of GABA B R or inhibition of α9α10 nAChRs is the analgesic mechanism. To investigate the mechanisms by which α-conotoxins provide analgesia, we synthesized a suite of Vc1.1 analogues where all residues, except the conserved cysteines, in Vc1.1 were individually replaced by alanine (A), lysine (K), and aspartic acid (D). Our results show that the amino acids in the first loop play an important role in binding of the peptide to the receptor, whereas those in the second loop play an important role for the selectivity of the peptide for the GABA B R over α9α10 nAChRs. We designed a cVc1.1 analogue that is >8000-fold selective for GABA B R-mediated inhibition of high voltage-activated (HVA) calcium channels over α9α10 nAChRs and show that it is analgesic in a mouse model of chronic visceral hypersensitivity (CVH). cVc1.1[D11A,E14A] caused dose-dependent inhibition of colonic nociceptors with greater efficacy in ex vivo CVH colonic nociceptors relative to healthy colonic nociceptors. These findings suggest that selectively targeting GABA B R-mediated HVA calcium channel inhibition by α-conotoxins could be effective for the treatment of chronic visceral pain.


  • Organizational Affiliation

    Illawarra Health and Medical Research Institute (IHMRI), University of Wollongong , Wollongong , New South Wales 2522 , Australia.


Macromolecules

Find similar proteins by:  Sequence   |   3D Structure  

Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Alpha-conotoxin Vc1A22Conus victoriaeMutation(s): 2 
UniProt
Find proteins for P69747 (Conus victoriae)
Explore P69747 
Go to UniProtKB:  P69747
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP69747
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 100 
  • Conformers Submitted: 20 
  • Selection Criteria: structures with the lowest energy 

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data

  • Released Date: 2018-05-23 
  • Deposition Author(s): Clark, R.J.

Funding OrganizationLocationGrant Number
National Health and Medical Research Council (NHMRC, Australia)AustraliaAPP1049928
National Health and Medical Research Council (NHMRC, Australia)AustraliaAPP1126378
Australian Research Council (ARC)AustraliaFT100100476
Australian Research Council (ARC)AustraliaFL150100146

Revision History  (Full details and data files)

  • Version 1.0: 2018-05-23
    Type: Initial release
  • Version 1.1: 2018-06-27
    Changes: Data collection, Database references
  • Version 1.2: 2020-01-01
    Changes: Author supporting evidence, Data collection
  • Version 1.3: 2023-06-14
    Changes: Database references, Other